115 related articles for article (PubMed ID: 6151604)
1. [Plasma lysyl oxidase activity in human liver disease].
Suzuki H; Suzuki M; Akiyama S; Kasai N; Koike Y; Kono M; Okabe K
Nihon Shokakibyo Gakkai Zasshi; 1984 Nov; 81(11):2775-9. PubMed ID: 6151604
[No Abstract] [Full Text] [Related]
2. Serum lysyl oxidase activity in patients with various liver diseases.
Sakamoto M; Murawaki Y; Hirayama C
Gastroenterol Jpn; 1987 Dec; 22(6):730-6. PubMed ID: 2895030
[TBL] [Abstract][Full Text] [Related]
3. Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin.
Murawaki Y; Kusakabe Y; Hirayama C
Hepatology; 1991 Dec; 14(6):1167-73. PubMed ID: 1683640
[TBL] [Abstract][Full Text] [Related]
4. Increased lysyl oxidase activity in culture medium of nonparenchymal cells from fibrotic livers.
Konishi A; Iguchi H; Ochi J; Kinoshita R; Miura K; Uchino H
Gastroenterology; 1985 Oct; 89(4):709-15. PubMed ID: 2863189
[TBL] [Abstract][Full Text] [Related]
5. The existence of inhibited lysyl oxidase and the presence of multiple forms.
Shieh JJ; Sasaki T; Minamiura N; Yasunobu KT
Adv Exp Med Biol; 1977; 79():509-29. PubMed ID: 68666
[TBL] [Abstract][Full Text] [Related]
6. [The diagnostic importance of research on the lysyl oxidase activity in children with circumscribed scleroderma].
Kudrin VI; Lashmanova AP; Akimov VG; Grebeniuk VN
Vestn Dermatol Venerol; 1990; (5):14-6. PubMed ID: 1976287
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of lysyl oxidase in experimental hepatic fibrosis.
Wakasaki H; Ooshima A
Biochem Biophys Res Commun; 1990 Feb; 166(3):1201-4. PubMed ID: 1689573
[TBL] [Abstract][Full Text] [Related]
8. The activity of lysyl oxidase in experimental hepatic fibrosis.
McPhie JL
Hepatogastroenterology; 1981 Oct; 28(5):240-1. PubMed ID: 6124494
[TBL] [Abstract][Full Text] [Related]
9. Lysyl oxidase and collagenase in experimental acute and chronic liver injury.
Carter EA; McCarron MJ; Alpert E; Isselbacher KJ
Gastroenterology; 1982 Mar; 82(3):526-34. PubMed ID: 6119272
[TBL] [Abstract][Full Text] [Related]
10. Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.
Vadasz Z; Kessler O; Akiri G; Gengrinovitch S; Kagan HM; Baruch Y; Izhak OB; Neufeld G
J Hepatol; 2005 Sep; 43(3):499-507. PubMed ID: 16023247
[TBL] [Abstract][Full Text] [Related]
11. Serum isoamylases in liver diseases.
Tsianos EB; Jalali MT; Gowenlock AH; Braganza JM
Hepatogastroenterology; 1986 Dec; 33(6):247-9. PubMed ID: 3804182
[TBL] [Abstract][Full Text] [Related]
12. Increased activity of serum amine oxidases in granuloma annulare, necrobiosis lipoidica and diabetes.
Yuen CT; Easton D; Misch KJ; Rhodes EL
Br J Dermatol; 1987 May; 116(5):643-9. PubMed ID: 2885024
[TBL] [Abstract][Full Text] [Related]
13. Ribonuclease activities in liver tissue of patients with chronic liver diseases.
Tsuji H; Murai K; Akagi K; Fujishima M
Clin Chim Acta; 1990 Oct; 191(1-2):101-3. PubMed ID: 2073727
[No Abstract] [Full Text] [Related]
14. Clinical significance of serum guanase activity in various liver diseases.
Shiota G; Fukada J; Ito T; Tsukizawa M; Yamada M; Sato M
Jpn J Med; 1989; 28(1):22-4. PubMed ID: 2542677
[TBL] [Abstract][Full Text] [Related]
15. [Serum cathepsin activity in chronic liver diseases].
Kucharz EJ; Kucharz M
Z Gesamte Inn Med; 1986 Nov; 41(22):636-8. PubMed ID: 3031888
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic and prognostic significance of cholinesterase (CHE) in chronic liver diseases].
Magris D; Mottola A; Mian G; Minutillo S; Triolo L; D'Agnolo B
Minerva Med; 1979 Feb; 70(6):483-7. PubMed ID: 431868
[No Abstract] [Full Text] [Related]
17. [Erythrocyte levels of the enzyme ALA-dehydrase in various kinds and stages of liver disease].
Sánchez Rodríguez A; Pérez Sandoval D; Cruz Hernández JJ; Rico Sánchez J; Juanes González A
Rev Clin Esp; 1983 Jan; 168(2):87-90. PubMed ID: 6856907
[No Abstract] [Full Text] [Related]
18. Studies on the in-vitro biotransformation in patients with liver diseases.
Truckenbrodt J; Kraul H; Machnik G; Volland R; Hoffmann A
Gastroenterol J; 1989; 49(3):126-8. PubMed ID: 2629781
[TBL] [Abstract][Full Text] [Related]
19. [Serum cholinesterase activity (CHE) in different classes of chronic liver diseases (author's transl)].
Galanti B; Russo M; Nardiello S; Guarino F
Quad Sclavo Diagn; 1978 Mar; 14(1):95-102. PubMed ID: 746115
[TBL] [Abstract][Full Text] [Related]
20. Lysyl Oxidase as a Serum Biomarker of Liver Fibrosis in Patients with Severe Obesity and Obstructive Sleep Apnea.
Mesarwi OA; Shin MK; Drager LF; Bevans-Fonti S; Jun JC; Putcha N; Torbenson MS; Pedrosa RP; Lorenzi-Filho G; Steele KE; Schweitzer MA; Magnuson TH; Lidor AO; Schwartz AR; Polotsky VY
Sleep; 2015 Oct; 38(10):1583-91. PubMed ID: 26085300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
